Skip to main content
. 2024 Oct 19;6(11):521–528. doi: 10.1253/circrep.CR-24-0110

Table 4.

Clinical Outcomes

Outcome / Valve position No. patients
with event (%)
Per 100
PY
Unadjusted HR
(95% CI)
P value Adjusted HR
(95% CI)
P value
Composite outcome
 Aortic 90 (15.3) 12.7 Ref. Ref.
 Mitral 25 (12.8) 10.2 0.80 (0.52–1.25) 0.333 0.89 (0.51–1.54) 0.669
 Both 16 (14.4) 11.8 0.92 (0.54–1.57) 0.768 1.10 (0.58–2.09) 0.773
Stroke/systemic embolism
 Aortic 14 (2.4) 1.90 Ref. Ref.
 Mitral 4 (2.1) 1.59 0.84 (0.28–2.56) 0.761 0.54 (0.13–2.13) 0.375
 Both 4 (3.6) 2.90 1.55 (0.51–4.72) 0.437 0.50 (0.09–2.72) 0.424
Stroke
 Aortic 12 (2.0) 1.62 Ref.
 Mitral 3 (1.5) 1.19 0.74 (0.21–2.61) 0.637
 Both 3 (2.7) 2.16 1.36 (0.38–4.80) 0.638
Systemic embolism
 Aortic 2 (0.3) 0.27 Ref.
 Mitral 1 (0.5) 0.40 1.49 (0.14–16.38) 0.747
 Both 1 (0.9) 0.72 2.73 (0.25–30.06) 0.413
Major bleeding
 Aortic 17 (2.9) 2.31 Ref. Ref.
 Mitral 1 (0.5) 0.40 0.17 (0.02–1.30) 0.088 0.14 (0.02–1.22) 0.075
 Both 3 (2.7) 2.15 0.94 (0.28–3.21) 0.922 0.44 (0.09–2.32) 0.335
HF requiring hospitalization
 Aortic 42 (7.1) 5.79 Ref. Ref.
 Mitral 18 (9.2) 7.32 1.26 (0.72–2.19) 0.415 1.73 (0.85–3.53) 0.131
 Both 4 (3.6) 2.90 0.49 (0.18–1.37) 0.176 1.00 (0.34–2.96) 1.000
All-cause death
 Aortic 33 (5.6) 4.42 Ref. Ref.
 Mitral 8 (4.1) 3.17 0.71 (0.33–1.54) 0.387 0.73 (0.29–1.83) 0.504
 Both 6 (5.4) 4.30 0.97 (0.41–2.31) 0.938 1.19 (0.42–3.35) 0.749
BPV reoperation
 Aortic 5 (0.9) 0.67 Ref.
 Mitral 1 (0.5) 0.40 0.60 (0.07–5.13) 0.640
 Both 1 (0.9) 0.72 1.08 (0.13–9.24) 0.945

BPV, bioprosthetic valve; CI, confidence interval; HF, heart failure; HR, hazard ratio; PY, patient-years.